Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Currency / FX Impact (% pts): 0.0% in FY2025, up 1.0 pts from a year earlier.
Latest, FY2025
0.0%
Period ended Dec 31, 2025
Change on a year earlier
+1.0 pts
-1.0% in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below
Where the FY2025 figure comes from
“|| Net sales to third parties | 8 | 8 | 0”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K (Operating Review).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Currency / FX Impact (% pts) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0.0% | +1.0 pts | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | -1.0% | +1.0 pts | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2023 | Dec 31, 2023 | -2.0% | +6.0 pts | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2022 | Dec 31, 2022 | -8.0% | -10.0 pts | Novartis Form 6-K (0001370368-23-000008) ↗ |
| FY2021 | Dec 31, 2021 | 2.0% | +3.0 pts | Novartis Form 6-K (0001370368-22-000009) ↗ |
| FY2020 | Dec 31, 2020 | -1.0% | – | Novartis Form 6-K (0001370368-21-000008) ↗ |
Cite this data
StockData. (2026). Novartis Currency / FX Impact (% pts) (%), annual FY2020–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/bridge-currency-pp
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.